Adenovirus Clinical Trials 2023

Adenovirus Clinical Trials 2023

Adenovirus research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in adenovirus clinical trials today.

Trials for Cytomegalovirus Patients

Trials for CMV Patients

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to adenovirus

What are the top hospitals conducting adenovirus research?

In the realm of clinical trials for adenovirus, several top hospitals are making significant strides in research and treatment. Nestled in Duarte, California, City of Hope is leading the charge with three active adenovirus trials and a total of three completed trials to date. Their first recorded trial took place in 2018, showcasing their commitment to exploring innovative approaches against this viral infection. In Washington D.C., Children's National Medical Center is also at the forefront with three ongoing adenovirus trials as well as a portfolio that includes six past studies since embarking on their first trial back in 2010.

Moving further north to Minneapolis, Minnesota, researchers at the University of Minnesota are actively engaged in three current adenovirus trials while having already conducted six previous investigations into this condition since launching their inaugural study in 2014. Meanwhile, Cleveland Clinic located in Ohio has two ongoing clinical tests dedicated to combating adenovirus alongside five accomplished studies that have been conducted over time after initiating its pioneering investigation on such cases starting from 2010.

Lastly but not least, Phoenix Children's Hospital situated amidst Arizona's capital city adds its name to this esteemed list with two active trials focused on combating adenovirus and contributing towards advancing our understanding through an additional three previously held investigations; theirs can be traced back only seven years ago when they commenced their maiden experiment revolving around this condition.

These prestigious medical institutions underscore efforts being made across locations and specialties to combat adenovirus infections effectively. The dedication displayed by these hospitals demonstrates a shared commitment towards finding better treatments and preventive measures against this viral menace which continues affecting individuals worldwide

Which are the best cities for adenovirus clinical trials?

Houston, Texas emerges as the leading city for adenovirus clinical trials with 12 ongoing studies. The trials in Houston focus on various treatments such as HLA-matched VSTs, Arm 1 Intratumoral LOAd703, and SAM-LNP-S. Saint Louis, Missouri follows closely behind with 9 active trials investigating Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF, SAM-LNP-S, and Posoleucel (ALVR105). New york City also showcases promising research with 7 active trials exploring therapies like Posoleucel and Virus Specific T-cell (VST) infusion. Dallas, Texas and Los Angeles, California both have 6 active trials each that encompass a range of treatments including Posoleucel and Virus Specific T-cell (VST) infusion. These cities offer individuals seeking adenovirus clinical trial opportunities access to cutting-edge research options that may shape future treatment approaches.

Which are the top treatments for adenovirus being explored in clinical trials?

Adenovirus research is paving the way for potential new treatments, with two standout contenders being explored in clinical trials. First on the list is HLA-matched VSTs, currently undergoing investigation in one active trial exclusively focusing on adenovirus. This treatment approach made its debut in 2021 and shows promising potential. Another noteworthy contender is virus-specific T-cell (VST) infusion, also being tested in one active trial dedicated to tackling adenovirus infections. Initially listed back in 2018, this treatment avenue holds great promise for combating this viral menace. As researchers delve deeper into these innovative therapies, there's hope that effective solutions will emerge to combat adenovirus and improve patient outcomes worldwide.

What are the most recent clinical trials for adenovirus?

Recent clinical trials have brought forth promising advancements in the field of adenovirus treatment. One such trial, known as Cohort A, has entered Phase 2 and became available on September 1, 2023. Additionally, a Phase 1 study involving virus-specific cytotoxic T-lymphocytes for adenovirus was made accessible on January 6, 2023. Another Phase 1 trial focused on Ad5-yCD/mutTKSR39rep-ADP adenovirus and fSRS Arm for adenovirus commenced on November 29th,2022. Notably, the TILT-123 trial began its first phase of testing on May17th ,2022 while Posoleucel reached Phase III and became available from May11th ,2022 . These recent clinical trials are propelling us closer to effective treatments against adenovirus infections.

What adenovirus clinical trials were recently completed?

Recently completed clinical trials investigating adenovirus therapies have yielded promising results, highlighting the potential of this innovative treatment approach. These trials include a study sponsored by Novartis Pharmaceuticals Corporation that concluded in March 2021 and focused on evaluating an adenovirus-based therapy for respiratory diseases. Another notable trial was conducted by Johnson & Johnson and successfully completed in January 2021, exploring the use of an adenovirus vector vaccine against COVID-19. These advancements signify significant strides in harnessing the power of adenoviruses for therapeutic purposes and offer hope for future breakthroughs in treating various medical conditions.